Hikma Pharmaceuticals is expanding its operations in Ohio, focusing on oral solid dose and nasal inhalation products, supported by state tax credits.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hikma Pharmaceuticals is expanding its operations in Ohio, focusing on oral solid dose and nasal inhalation products, supported by state tax credits.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hikma Pharmaceuticals
UK-headquartered pharmaceutical company
Nothing else this week.
-
Columbus
capital city of Ohio, United States of America
-
Ohio
state of the United States of America